Terms: = Thyroid cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5
418 results:
1. [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
Li ZM; Liang ZH; Liu N; Wei KR
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):232-238. PubMed ID: 38494769
[No Abstract] [Full Text] [Related]
2. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
Su H; Hao JJ; Xu YB; Zhang FH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
[TBL] [Abstract] [Full Text] [Related]
3. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
4. Analyzing cancer Incidence Trends in Oman From 1996 to 2019: A Comprehensive Study of the National cancer Annual Reports.
Al-Sayegh H; Al-Zadjali S; Al-Moundhri M
JCO Glob Oncol; 2024 Jan; 10():e2300337. PubMed ID: 38271648
[TBL] [Abstract] [Full Text] [Related]
5. Thirty-two-year trends of cancer incidence by sex and cancer site in the Veneto Region from 1987 to 2019.
Buja A; De Luca G; Zorzi M; Bovo E; Mocellin S; Trevisiol C; Bronte V; Guzzinati S; Rugge M
Front Public Health; 2023; 11():1267534. PubMed ID: 38259775
[TBL] [Abstract] [Full Text] [Related]
6. Radiation Dose Does Not Affect the Predictive Value of thyroid Biopsy for Diagnosing Papillary thyroid cancer in a Belarusian Cohort Exposed to Chernobyl Fallout.
McConnell RJ; Kamysh O; O'Kane PL; Greenebaum E; Rozhko AV; Yauseyenka VV; Minenko VF; Drozdovitch V; Yarets Y; Kukhta T; Mabuchi K; Little MP; Cahoon EK; Zablotska LB
Acta Cytol; 2024; 68(1):34-44. PubMed ID: 38246154
[TBL] [Abstract] [Full Text] [Related]
7. Genetic predisposition to differentiated thyroid cancer in the Polish population.
Borowczyk M; Sypniewski M; Szyda J; Braszka M; Ziemnicka K; Ruchała M; Oszywa M; Król ZJ; Dobosz P
Pol Arch Intern Med; 2024 Mar; 134(3):. PubMed ID: 38165228
[TBL] [Abstract] [Full Text] [Related]
8. Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal.
Gonçalves E; Fontes F; Rodrigues JR; Calisto R; Bento MJ; Lunet N; Morais S
Breast Cancer Res Treat; 2024 Apr; 204(2):367-376. PubMed ID: 38151690
[TBL] [Abstract] [Full Text] [Related]
9. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract] [Full Text] [Related]
10. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
11. A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
Kanankulam Velliangiri S; Ballal S; Prasad Yadhav M; Tripathi M; Satapathy S; Bal C
PLoS One; 2023; 18(11):e0294343. PubMed ID: 37963164
[TBL] [Abstract] [Full Text] [Related]
12. Geographic disparities in trends of thyroid cancer incidence and mortality from 1990 to 2019 and a projection to 2030 across income-classified countries and territories.
Wang C; Wu Z; Lei L; Dong X; Cao W; Luo Z; Zheng Y; Wang F; Xu Y; Zhao L; Shi J; Ren J; Li J; Zhang Y; Chen W; Li N
J Glob Health; 2023 Sep; 13():04108. PubMed ID: 37766638
[TBL] [Abstract] [Full Text] [Related]
13. Smoking and alcohol consumption with the risk of 11 common otolaryngological diseases: a bidirectional Mendelian randomization.
Wang X; Bi Y; Liu G; Wang W; Cui H
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5615-5623. PubMed ID: 37752250
[TBL] [Abstract] [Full Text] [Related]
14. Long-Term Changes in the Mortality Rates of thyroid cancer in Korea: Analysis of Korean National Data from 1985 to 2020.
Choi YM; Kim MJ; Lee J; Kwak MK; Jeon MJ; Kim TY; Hong EG; Kim WB; Kim WG
Endocrinol Metab (Seoul); 2023 Oct; 38(5):588-595. PubMed ID: 37679950
[TBL] [Abstract] [Full Text] [Related]
15. Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.
Yang J; Han Y; Min Y; Chen C; Chen J; Xiang K; Liao J; Feng Y; Hu D; Yin G
Front Endocrinol (Lausanne); 2023; 14():1176512. PubMed ID: 37576962
[TBL] [Abstract] [Full Text] [Related]
16. Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019.
Siegel DA; King JB; Lupo PJ; Durbin EB; Tai E; Mills K; Van Dyne E; Buchanan Lunsford N; Henley SJ; Wilson RJ
J Natl Cancer Inst; 2023 Nov; 115(11):1337-1354. PubMed ID: 37433078
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
18. Cribriform Morular thyroid Carcinoma - Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case.
Dettmer MS; Hürlimann S; Scheuble L; Vassella E; Perren A; Wicke C
Endocr Pathol; 2023 Sep; 34(3):342-348. PubMed ID: 37249797
[TBL] [Abstract] [Full Text] [Related]
19. Global thyroid cancer incidence trend and age-period-cohort model analysis based on Global Burden of Disease Study from 1990 to 2019.
Xu L; Cao ZX; Weng X; Wang CF
Front Endocrinol (Lausanne); 2023; 14():1133098. PubMed ID: 37124740
[TBL] [Abstract] [Full Text] [Related]
20. Immune-related thyroid dysfunctions during anti PD-1/PD-L1 inhibitors: new evidence from a single centre experience.
Nervo A; Ferrari M; Gruosso G; Migliore E; Basile S; D'Angelo V; Roux A; Piovesan A; Arvat E
Clin Exp Med; 2023 Dec; 23(8):4817-4824. PubMed ID: 37103651
[TBL] [Abstract] [Full Text] [Related]
[Next]
